Search
for
Sort by
Research 781–810 of 1000+
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Regenerative Strategies for Androgenetic Alopecia: Evidence, Mechanisms, and Translational Pathways
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Real-world evidence in alopecia areata treatment: A narrative review
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Targeting integrin pathways: mechanisms and advances in therapy
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Regenerative Medicine Therapy in Malaysia: An Update
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Botulinum Toxins in Medical and Cosmetic Dermatology
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Updates in Treatment for Androgenetic Alopecia
- Recent advances in the role of neuroregulation in skin wound healing
- Role of Extracellular Vesicles as Mediators of Cell Communication and Novel Biomarkers in Sepsis
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Prostate Cancer Early Detection, Version 2.2015
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
- Nitroxide pharmaceutical development for age-related degeneration and disease
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives